Unraveling Neurodegeneration: Common Molecular Mechanisms and Novel Therapeutic Concepts in Major Neurodegenerative Disorders
Brain and Behavior · 2026
DOI: 10.1002/brb3.71615 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain and Behavior, 2026. Verfasst von Fatemeh Sadat Aldaghi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Science, University of Guilan, Rasht, Iran. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Neuroinflammatory Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Although Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and Huntington's disease (HD) present with markedly different clinical phenotypes, these neurodegenerative diseases (NDDs) appear to converge on a shared set of underlying molecular disturbances. This review sought to integrate disease‐specific causative triggers with shared pathogenic pathways, focusing on neuroinflammatory signaling, oxidative imbalance, mitochondrial impairment, and disrupted protein homeostasis, in order to support multi‐target, disease‐modifying therapeutic strategies.
Method
Relevant classical and contemporary literature, encompassing original research and review articles on the molecular basis of AD, PD, ALS, MS, and HD, was reviewed and synthesized narratively, with attention to how neuroinflammatory and oxidative stress pathways intersect, reinforce one another through mitochondrial and inflammasome‐driven feedback, and recur across the five conditions. Finding In each disorder, persistently activated microglia and astrocytes secreted inflammatory mediators and reactive oxygen species, engaged the NLRP3 inflammasome, and progressively destabilized cellular homeostasis through a self‐perpetuating cycle linking neuroinflammation and oxidative stress. Disease‐specific lesions nonetheless persisted: amyloid‐β and tau pathology in AD; α‐synuclein aggregation with iron‐driven mitochondrial damage in PD; RNA‐binding protein dysfunction, proteostatic collapse, and excitotoxicity in ALS; inflammatory demyelination and axonal bioenergetic failure in MS; and mutant huntingtin‐driven transcriptional and mitochondrial disruption in HD. These distinct triggers ultimately converged on shared downstream cascades.
Conclusion
Recognizing this shared pathogenic foundation supports multi‐target therapies—such as Nrf2 activation, NLRP3 inhibition, mitochondria‐targeted antioxidants, and gene‐based interventions—that extend across diagnostic boundaries, though challenges in intervention timing, patient stratification, and clinical translation remain unresolved.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Faculty of Science, University of Guilan, Rasht, Iran.
- Faculty of Chemistry, University of Guilan, Rasht, Iran.
ORCID-Profile: Zivar Salehi
Zitieren
APA
Aldaghi, F. S., Siahpoosh, Z., Salehi, Z., Mashayekhi, F., & Sohrabnezhad, S. (2026). Unraveling Neurodegeneration: Common Molecular Mechanisms and Novel Therapeutic Concepts in Major Neurodegenerative Disorders. Brain and Behavior. https://doi.org/10.1002/brb3.71615
Vancouver
Aldaghi FS, Siahpoosh Z, Salehi Z, Mashayekhi F, Sohrabnezhad S. Unraveling Neurodegeneration: Common Molecular Mechanisms and Novel Therapeutic Concepts in Major Neurodegenerative Disorders. Brain and Behavior. 2026. doi:10.1002/brb3.71615
BibTeX
@article{Aldaghi2026,
author = {Aldaghi, Fatemeh Sadat and Siahpoosh, Zakieh and Salehi, Zivar and Mashayekhi, Farhad and Sohrabnezhad, Shabnam},
title = {Unraveling Neurodegeneration: Common Molecular Mechanisms and Novel Therapeutic Concepts in Major Neurodegenerative Disorders},
journal = {Brain and Behavior},
year = {2026},
doi = {10.1002/brb3.71615}
}
EUVIMED